SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (407)9/22/2003 3:03:40 PM
From: nigel bates  Read Replies (1) | Respond to of 625
 
The Celltrix (Insmed) TGF beta patents:

1 5,783,185 Monoclonal antibodies to transforming growth factor-beta and methods of use
2 5,772,998 Monoclonal antibodies to transforming growth factor-beta and methods of use
3 5,674,843 Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor .beta.
4 5,571,714 Monoclonal antibodies which bind both transforming growth factors .beta.1 and .beta.2 and methods of use
5 5,462,925 Transforming growth factor .beta.2,3
6 5,426,098 Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta